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Abstract
In this paper, we investigate potential biases in datasets used to make drug binding
predictions using machine learning. We investigate a recently published metric called
the Asymmetric Validation Embedding (AVE) bias which is used to quantify this bias
and detect overfitting. We compare it to a slightly revised version and introduce a new
weighted metric. We find that the new metrics allow to quantify overfitting while not
overly limiting training data and produce models with greater predictive value.
1 Introduction
Protein-ligand interactions are important to most processes in the human body, and therefore
to regulating disease via drugs. There are an estimated 20,000 different human protein-coding
genes1, and 1060 small molecules in the chemical universe.2 Clearly, exploring all possible
protein–drug pairs is not experimentally feasible. Drug discovery programs need accurate
computational methods to predict protein–drug binding, and advances in machine learning
1with about one-eighth of the exome containing observable genetic variations1
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have improved the accuracy of these predictions used in early stages of drug discovery. Area
under the curve (AUC) scores for various curves are often provided to support suitability of
a machine learning model for use in drug binding prediction— in this paper we focus on the
Precision–Recall curve and its associated AUC (PR-AUC).
The primary goal in protein–ligand binding modeling is to produce models that are capa-
ble of making accurate predictions on novel protein–drug pairs. Consequently, performance
metrics need to reflect expected performance on novel data. This effort is frustrated by
benchmark datasets that are not well-sampled from chemical space, so that novel pairs may
be relatively far from data available to the modeler. Care must be taken in interpreting per-
formance metrics like the PR-AUC, as laboratory experiments reveal that inferring real-world
performance from AUC alone is overly-optimistic. This issue of generalizability is common
in machine learning applications, but is particularly relevant in settings with insufficient and
non-uniformly distributed data, as is the case with drug binding data.
The phenomenon of high performance metrics for low quality models is called overfitting,
and is typically combated by using different data for the processes of model training and
validation. If the validation data and real-world data for the model application are both
distinct from the training data, then we expect the performance metrics on the validation
data to be representative of the real-world performance of the model. A common way of
splitting the available data into training and validation sets is to select a training ratio and
randomly assign that proportion of the data to the training set.
A developing framework to account for overfitting is based on the assumption that the
Nearest Neighbor (NN) model has poor generalizability. Within the context of reporting
“fair” performance metrics, this working assumption of poor generalizability of NN models
suggests several possibilities for more informative metrics, including:
1. reporting the PR-AUC for a model produced from a training/validation split on which
the Nearest Neighbor model has poor performance, and
2. designing a metric which weights each validation molecule according to its relative
2
distance to the binding classes in the training set.
We describe implementations of each of these approaches in this paper. For the first ap-
proach, we discuss the efforts presented in the Atomwise paper3 to produce training/validation
splits that are challenging for NN models, hereafter refered to as the Atomwise algorithm.
We also describe two variations of the Atomwise algorithm: ukySplit–AVE and ukySplit–VE.
As distinct from optimization, we introduce a weighting scheme ω designed to address the
second approach, and discuss the consequences of using an ω-weighted PR-AUC versus the
traditional PR-AUC with a training/validation split produced by the ukySplit–AVE algo-
rithm.
1.1 Current Bias Quantification Methods
Datasets with a metric feature space can be evaluated using spatial statistics4 to quantify the
dataset topology and better understand potential biases. Of particular interest in the area of
drug–binding model generalization are the “nearest neighbor function” G(t) and the “empty
space function” F(t). G(t) is the proportion of active compounds for whom the distance to
the nearest active neighbor is less than t. F(t) is the proportion of decoy compounds for
whom the distance to the nearest active neighbor is less than t. Letting
∑
G and
∑
F denote
the sum of the values of G and F over all thresholds t, it is reported that large values of
∑
G
indicate a high level of self-similarity and that small values of
∑
F indicate a high degree
of separation. The difference of
∑
G and
∑
F gives a quick and interpretable summary of
a dataset’s spatial distribution, with negative values indicating clumping, near-zero values
indicating a random-like distribution, and positive values indicating larger active-to-active
distance than decoy-to-active. These spatial statistics were used to develop the Maximum
Unbiased Validation (MUV) dataset, with the goal of addressing the reported association of
dataset clumping with overly–optimistic virtual screening results.4,5
Wallach et al.3 extended the MUV metric, and used it to quantify the spatial distribution
of actives and decoys among the training and validation sets. For two subsets V and T of a
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metric data set with distance function d, define, for each v in V , the function It(v, T ) to be
equal to one if minw∈T{d(v, w)} < t and zero otherwise. For a fixed value of n, define the
function H(V,T ) by
H(V,T ) =
1
n+ 1
· 1|V |
∑
v∈V
(
n∑
i=0
Ii/n(v, T )
)
. (1)
Then the Asymmetric Validation Embedding (AVE) bias is defined to be the quantity
B(VA, VI , TA, TI) = H(VA,TA) −H(VA,TI) +H(VI ,TI) −H(VI ,TA), (2)
where the value of n is taken to be 100, and where VA and VI are the validation actives
and inactives (decoys), respectively, and similarly TA and TI are the training actives and
inactives. For convenience, we abbreviate H(Va, Ta) − H(Va, Ti) and H(Vi, Ti) − H(Vi, Ta)
as (AA − AI) and (II − IA), respectively. They are intended to be a quantification of the
“clumping” of the active and decoy sets. If the term (AA−AI) is negative, it suggests that,
in the aggregate, the validation actives are closer to training decoys than to training actives,
with the consequence that the active set is expected to be challenging to classify. If the sum
of (AA − AI) and (II − IA) (the AVE bias) is close to zero, it is expected that the data
set is “fair”, in that it does not allow for easy classification due to clumping. The authors
also provide an AVE bias minimization algorithm. It is a genetic algorithm with breeding
operations: merge, add molecule, remove molecule, and swap subset. The algorithm first
generates initial subsets through random sampling, measures the bias, and selects subsets
with low biases for breeding. The algorithm repeats bias scoring, redundancy removal, and
breeding until termination based on minimal bias or maximum iterations.
In their paper, Wallach et al. observe that AUC scores2 and AVE bias scores are positively
correlated for several benchmark data sets, implying that model performance is sensitive to
the training/validation split.
In this paper, we present an efficient algorithm for minimizing the AVE bias of train-
2They report ROC-AUC scores, as opposed to PR-AUC scores.
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ing/validation splits. We introduce a variation on the AVE bias, which we call the VE score,
and describe its advantages in the context of optimization. We investigate the efficacy of
minimizing these metrics for training/validation splits, and conclude by proposing a weighted
performance metric as an alternative to the practice of optimizing training/validation splits.
2 Methods
2.1 Dataset
Dekois 26 provides 81 benchmark datasets: 80 with unique proteins, and one with separate
datasets for two different known binding pockets in the same protein. The active sets are
extracted from BindingDB.7 Weak binders are excluded, and 40 distinct actives are selected
by clustering Morgan fingerprints by Tanimoto similarity. Three datasets are extended by
selecting up to 5 actives from each structurally diverse cluster. The decoy set is generated
using ZINC8 and property matched to the actives based on molecular weight, octanol-water
partition coefficient (logP), hydrogen bond acceptors and donors, number of rotatable bonds,
positive charge, negative charge, and aromatic rings. Possible latent actives in the decoy set
are removed using a score based on the Morgan fingerprint and the size of the matching
substructures. Any decoy that contained a complete active structure as a substructure is
also removed.
2.2 Bias metrics
Throughout this paper, the term fingerprint refers to the 2048-bit Extended Connectivity
Fingerprint (ECFP6) of a molecule as computed by the Python package RDKit.9 For sim-
plicity, we define
d(v, T ) := min
t∈T
{d(v, t)}
5
and
Γ(v, T ) :=
bn · d(v, T )c
n+ 1
,
where d(v, t) is the Tanimoto distance between the fingerprints of the molecules v and t. We
compute the AVE bias via the expression
meanv∈VA{Γ(v, TI)− Γ(v, TA)}+ meanv∈VI{Γ(v, TA)− Γ(v, TI)}, (3)
where VA and VI are the validation actives and inactives (decoys), respectively, and similarly
TA and TI are the training actives and inactives. For a derivation of the equivalence of this
expression and Expression (2), see the Appendix. Since
|d(v, T )− Γ(v, T )| < 1
n+ 1
,
for large values of n Expression (3) (and hence the AVE bias) is an approximation of
meanv∈VA{d(v, TI)− d(v, TA)}+ meanv∈VI{d(v, TA)− d(v, TI)}. (4)
We now introduce the VE score, a close relative of the AVE bias:
√
mean2v∈VA{d(v, TI)− d(v, TA)}+ mean2v∈VI{d(v, TA)− d(v, TI)}. (5)
While the raw ingredients of the AVE bias and the VE score are the same, they are qualita-
tively different, in particular as the VE score is never negative.
We generate a random training/validation split for each Dekois target and evaluate Ex-
pressions (2) through (5) 1,000 times with a single thread on an AMD Ryzen 7 2700x
eight-core processor. We compare the mean computation times, as well as the computed
values.
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2.3 Split Optimization
We implement two custom genetic optimizers, ukySplit-AVE and ukySplit-VE, using the
open source DEAP10 framework. For a comparison of ukySplit-AVE and the Atomwise
algorithm, see the Appendix. Both ukySplit-AVE and ukySplit-VE optimizers use parame-
ters as described in Table 1. The parameters were chosen after grid-searching for minimum
mean-time-to-debias on a sample of the Dekois targets.
Table 1: Evolutionary algorithm parameters
Parameter Name Meaning Value
POPSIZE Size of the population 500
NUMGENS Number of generations in the optimization 2000
TOURNSIZE Tournament Size 4
CXPB Probability of mating pairs 0.175
MUTPB Probability of mutating individuals 0.4
INDPB Probability of mutating bit of individual 0.005
The optimizer populations consisted of training/validation splits, and the objective func-
tions were given by Expressions (3) and (5), respectively, for valid splits, and equal to 2.0
otherwise. We say that a split is valid if
1. the validation set contains at least one active and one decoy molecule,
2. the active/decoy balance in the validation set is within 5% of that in the total dataset,
3. the ratio of training/validation set sizes is 80± 1%.
2.4 Modeling
Using scikit-learn,11 we train a random forest classifier (n estimators = 100) with stratified
5-fold cross-validation and compute the mean PR-AUC for each target of the Dekois data set.
We use fingerprints as features, and take the probability of the active class as the output
of the model. For each of the folds, we evaluate the Expressions (3) and (5), and report
Pearson correlation coefficients with the PR-AUC.
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For the training/validation splits produced by an optimizer, we compute PR-AUC of a
random forest model and evaluate Expression (3) or (5) as applicable.
2.5 Nearest Neighbor similarity
We gather the binary predictions made by the Nearest Neighbor model, which predicts the
class of a validation molecule to be the same as its nearest neighbor (using the metric d) in
the training set. Considering the NN predictions as a bit string, we can compare it with the
prediction bit string of any other model M using the Tanimoto similarity T :
T (NN,M) =
∑
(NN ∧M)∑
(NN ∨M) ,
with bitwise operations ∧ (and) and ∨ (or) and sums over all predictions for the validation
set. We take the maximum Tanimoto similarity over all thresholds η for each of the validation
folds, and report the mean.
2.6 Weighted PR-AUC
For a given model, let TP, TN, FP, and FN be the collections of molecules for which the model
predictions are true positive, true negative, false positive, and false negative, respectively.
The metrics precision and recall may be easily generalized by assigning a weight ω(v) to each
molecule v, and letting the ω–weighted precision be given by
∑
v∈TP ω(v)∑
v∈TP ω(v) +
∑
v∈FP ω(v)
and the ω–weighted recall be given by
∑
v∈TP ω(v)∑
v∈TP ω(v) +
∑
v∈FN ω(v)
.
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Setting the weight ω(v) equal to 1 for all molecules v, we recover the standard definitions of
precision and recall.
Inspired by Expression (4), we define the ratio γ(v) by
γ(v) =

d(v,TA)
d(v,TI)
if v is active,
d(v,TI)
d(v,TA)
if v is decoy.
When we refer to the weighted PR-AUC in this paper we use the weight ω given by the
cumulative distribution function of γ over the validation set for the target protein. Note that
the weights ω are between zero and one, and that the weighting de-emphasizes molecules
that are closer to training molecules of the same binding class than to training molecules of
the opposite class. Thus the larger the contribution of a molecule to the AVE bias, the lower
its weight. For further description of the ω–weighted PR-AUC, see the Appendix.
2.7 Generalization Ability
Inspired by recent work presented on the so-called “far AUC”,12 we attempt to measure
the ability of a drug-binding model to generalize. We randomly split the data set for each
target 80/20 (preserving the class balance), then remove any molecules in the 80% set that
are distance less than 0.4 from the 20% set. We reserve the 20% set to serve as a proxy
for novel data “far” from the training data. We then treat the remainder of the 80% as a
data set, running the same analysis as described in the earlier subsections: computing the
weighted and un-weighted PR-AUC of a random forest trained on random splits, as well as
the PR-AUC of random forest models trained on ukySplit-AVE and ukySplit-VE optimized
splits.
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3 Results
3.1 Computational Efficiency
A naive implementation of Equation (2) required a mean computation time over all Dekois
targets of 7.14 ms, while an implementation of Equation (3) had a mean computation time of
0.99 ms. The mean computation times for Expressions (4) and (5) were both approximately
0.31 ms.
Table 2: Computational Efficiency
Expression Mean Computation Time Relative Speedup
(2) 7.14 ms 1
(3) 0.99 ms 7.2
(4) 0.31 ms 23.4
(5) 0.31 ms 23.1
Evaluations of Expressions (2) through (5) are plotted in Figure 1. The absolute dif-
ferences between the computed value of Expression (2) and Expressions (3) and (4) are
summarized in Table 3. It is not meaningful to compare the evaluations of Expressions (2)
and (5) in this way, as they measure different, though related, quantities.
Table 3: Comparison with Expression (2) over Dekois targets
Expression Mean Abs Difference Max Abs Difference
(3) 3.1× 10−4 4.1× 10−3
(4) 9.9× 10−3 2.3× 10−2
For reference, the AVE paper considered a score of 2× 10−2 to be “bias free”.
3.2 Split Bias and Model Performance
In Figure 2, we plot the mean PR-AUC against the mean AVE bias for 5-fold cross validation
on each Dekois target. The Pearson correlation coefficient between mean AVE bias and
mean PR-AUC is computed to be 0.80, which is comparable in strength to the correlation
reported in the AVE paper for other benchmark datasets. We also plot the AVE bias against
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Figure 1: Comparison of evaluations over Dekois targets
the mean PR-AUC for each target after optimization by ukySplit–AVE. Note that, although
the optimizer was run with a stopping criterion of 0.02, it is possible for the minimum AVE
bias to jump from greater than 0.02 to a negative number (as low as -0.2) in one generation.
Figure 2: Mean Split AVE Bias vs. Model PR-AUC.
We order the target proteins by AVE bias, and plot the two components, AA-AI and
II-IA, after optimization by ukySplit–AVE in Figure 3.
3.3 Optimization by ukySplit–VE
Figure 4 plots the mean VE score against the mean PR-AUC across each fold of the cross-
validation split for each target before and after optimization with ukySplit–VE (minimizing
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Figure 3: The two components of the AVE Bias score.
VE score as opposed to AVE bias). Figure 5 plots the score components associated to the
active and decoy validation molecules after optimizing VE score (for comparison with Figure
3).
Figure 4: Mean VE Score vs. Model PR-AUC.
3.4 Weighted Performance
Figure 6 plots the ω–weighted PR-AUC against the mean AVE bias over each fold for each
target. Recall that the models and predictions are the same as those represented in Figure 2
with label “random”, but that the contributions of each validation molecule to the precision
and recall are now weighted by the weight function ω.
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Figure 5: The two components of the VE Score.
Figure 6: Mean Split AVE Bias vs. Model Weighted PR-AUC.
3.5 Nearest Neighbor similarity
Figure 7 plots the NN- similarity of a random forest model trained on splits produced ran-
domly, by ukySplit-AVE, and by ukySplit-VE. The mean NN-similarities were 0.997, 0.971,
and 0.940, respectively.
3.6 Model Performance on Distant Data
After reserving 20% of each target’s data for the test set, approximately 3% of the remain-
der was found to be within the 0.4 buffer distance, and was removed before splitting into
training and validation sets. Similarly to Sundar and Colwell,12 we find that de-biasing
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Figure 7: NN similarity of a random forest model trained on various splits.
training/validation splits does not lead to increased performance on “distant” test sets: the
mean ratio of test PR-AUC before and after split optimization by ukySplit-AVE was 1.010
(1.018 for ukySplit-VE).
Figure 8 plots the AVE bias on the training/test split against the AVE bias on the
training/validation split (letting the test set play the role of the validation set in the AVE
bias definition). Figure 9 shows the validation and test PR-AUC of a model trained with a
training set produced randomly, by ukySplit-AVE, and by ukySplit-VE.
4 Discussion
4.1 Computing Bias
As presented in Table 2, refactoring Expression (2) into Expression (3) yielded speedups of
7x, and the additional use of exact, rather than approximated, values yielded a speedup of
roughly 23x for Expression (4). While Expressions (2) and (3) are mathematically equivalent,
in practice they yield slightly different results due to machine precision. In the aggregate
over the Dekois dataset, the difference is negligible relative to the established definition
of “de-biased”, as described in Table 3. Expressions (2) and (4) are not mathematically
equivalent. In light of the equivalence of Expressions (2) and (3), it is clear that AVE bias
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Figure 8: AVE bias of training/validation and training/test splits.
(Expression (2)) is an approximation of Expression (4). Their difference, though slight, is
properly interpreted as approximation error in the AVE bias.
4.2 Model effects of optimization
Figures 2 and 4 demonstrate that the process of minimizing bias in the training / validation
split risks training a model with little or no predictive value. The expected recall (and
precision) for a random guessing model is equal to the balance of active molecules, which for
the Dekois dataset is 3%. Of the 81 Dekois targets, 21 (about 26%) had models with below
random PR-AUC when trained and validated on a split produced by ukySplit–AVE. This
may be understood by considering Figure 3, which shows that the AVE bias is primarily an
indication of the spatial distribution of the (minority) active class in the validation set, with
low AVE bias associated with active validation molecules that are closer to training decoys
than to training actives. Models trained on such splits are therefore prone to misclassify
validation actives, and hence have a low PR-AUC. This phenomenon is less pronounced
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Figure 9: Model performance on validation vs. test set of a model trained on various splits.
when splits are optimized for VE score (ukySplit–VE), as it does not allow terms to “cancel
out”, and so does not incentivize pathological distributions of validation actives. Only one
Dekois target had worse-than-random performance for a model trained on a split optimized
for VE score, and while the mean PR-AUC over models trained with ukySplit–AVE splits
was 0.26, the mean PR-AUC for models trained on ukySplit–VE splits was 0.44.
As demonstrated in Figure 7, random forest models trained on ukySplit-AVE optimized
splits are still substantially similar to Nearest Neighbor models.
4.3 Weighted PR-AUC
As described in the Introduction, a weighted metric represents an alternative way of taking
into account the assumption of poor generalizability of Nearest Neighbor models. While bias
optimization creates training/validation splits that are more challenging for Nearest Neighbor
models, they simultaneously result in low quality models, even when using powerful methods
like random forests. In contrast, the weighted metric ω-PR-AUC discounts the potentially
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inflated performance of models without degrading the models themselves (see Figure 10). It
is worth noting, as well, that the computational expense of computing the weighting ω is
negligible compared with the intensive work performed in optimizing training / validation
splits.
Figure 10: Comparison of ukySplit-AVE, ukySplit-VE, and weighting methods.
Ultimately, we don’t claim that that the weighted PR-AUC is a good indicator of expected
model performance on novel data. Rather, it may be used to infer that the standard PR-
AUC is inflated due to the spatial distribution of the validation set. In particular, if two
trained models have the same performance, the one with the higher weighted performance
may be expected to have better generalizability.
4.4 Test Performance
Figure 8 shows that minimizing the AVE bias on the training/validation split does not
minimize the AVE bias on the training/test split. Figure 9 demonstrates that even when a
split results in a trained model with very low validation PR-AUC, the model still performs
fairly well on the test data.
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5 Conclusions
Developers of machine learning models for virtual high-throughput screening will have to
contend with issues of over-fitting as long as drug binding data is scarce. While optimization
of training/validation splits may have merit, the practice of minimizing AVE bias is not a
valid method for addressing this issue for several reasons:
1. the resulting models tend to have low predictive value,
2. minimizing the AVE bias of a training/validation split does not seem to effect the AVE
bias of the training/test split, and
3. the resulting models are still essentially equivalent to the nearest-neighbor model, and
are not expected to generalize well.
We propose the use of weighted performance metrics as a less computation-intensive
alternative to split optimization. We do not claim that the weighted metrics are more
representative of expected performance on novel data, but rather as a warning that overfitting
may be taking place. If the weighted and un-weighted metrics diverge, we can conclude that
the good performance of a model is concentrated at data points on which a nearest-neighbor
model is sufficient.
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6 Appendix
6.1 AVE bias
There is room for improvement in Equation (1):
H(V,T ) =
1
n+ 1
· 1|V |
∑
v∈V
(
n∑
i=0
Ii/n(v, T )
)
.
Notice that d < i/n if and only if nd < i. There are two cases to consider. First, if nd is an
integer, then nd < i if and only if nd ≤ i − 1. Second, if nd is not an integer, then nd < i
if and only if dnde ≤ i. In both cases, ∑ni=0 Ii/n(v, T ) is equal to the number of i satisfying
0 ≤ i ≤ n and nd < i, and in both cases this number is n− bndc.
For simplicity, we define
d(v, T ) := min
t∈T
{d(v, t)}
and
Γ(v, T ) :=
bn · d(v, T )c
n+ 1
.
Then
B(VA, VI , TA, TI) = meanv∈VA{Γ(v, TI)− Γ(v, TA)}+ meanv∈VI{Γ(v, TA)− Γ(v, TI)},
as presented in Equation (3).
6.2 Atomwise algorithm vs ukySplit-AVE
Of the 81 Dekois targets, ukySplit-AVE successfully removed the bias from 59, while Atom-
wise removed the bias from 26.
Among the targets for which neither method was successful in removing bias, the mean
final AVE bias scores were 0.15 and 0.24, respectively.
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Table 4: Breakdown of successes for Atomwise and ukySplit-AVE methods.
ukySplit-AVE Successful ukySplit-AVE Unsuccessful
Atomwise Successful 26 0
Atomwise Unsuccessful 33 22
6.3 Weighted PR-AUC
We give more details of the weighting scheme ω with the example of Dekois target protein
COX1. We generate a valid random split and for purposes of illustration choose an active
molecule v at random from the validation set. The distance to the nearest active in the
training set is 0.47, while the distance to the nearest decoy in the training set is 0.81. The
ratio γ(v) is then given by 0.47/0.81 = 0.58. Note that γ is less than one, indicating that
this validation molecule is closer to the training molecules of the same binding class than
the opposite binding class. The contribution of this molecule to the AVE bias of this split
is approximately (0.81 − 0.47)/23 = 0.015 (using Expression 4). The distribution of the
values of γ over the entire validation set is presented in Figure 11, and the corresponding
cumulative distribution is presented in Figure 12.
Figure 11: The distribution of γ.
The weight ω(v) for our example validation molecule is equal to 0.09, the evaluation
of the cumulative distribution function at γ(v) = 0.58. It may also be interpreted as the
percentile (9%) of the value of γ(v) among all γ values.
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Figure 12: The cumulative distribution of γ.
For a random forest model trained on this particular random split, the predicted proba-
bility that v is active is 0.4. Using a threshold value of 0.3, the resulting prediction is that
v is active (a true positive). With standard weights (ω = 1), the confusion matrix for this
threshold is given by Table 5, but with the weighting ω the table is given by Table 6.
Table 5: Confusion matrix for threshold 0.3
Pred Active Pred Decoy
Active 7 16
Decoy 2 575
Table 6: ω-weighted Confusion matrix for threshold 0.3
Pred Active Pred Decoy
Active 3.21 13.43
Decoy 1.25 331.65
The resulting precision and recall are 0.78 and 0.3, respectively, while the ω-weighted
precision and recall are .72 and 0.19, respectively. The decrease in these metrics indicates
that the molecules correctly classified by the model have below average weight, i.e., the
spatial distribution of the validation set is artificially inflating the performance metrics.
Repeating this calculation for threshold values between 0 and 1.0 yields the ω–weighted
precision recall curve, and we call the area under the curve the ω-PR-AUC.
23
